A Functional Polymorphism in the Cyp3a4 Gene is Associated with Increased Risk of Coronary Heart Disease in the Chinese Han Population

Bao-xia He,Lei Shi,Jian Qiu,Liang Tao,Rui Li,Liang Yang,Shu-jin Zhao
DOI: https://doi.org/10.1111/j.1742-7843.2010.00657.x
2011-01-01
Basic & Clinical Pharmacology & Toxicology
Abstract:CYP3A4 is a major member of the cytochrome P450 (CYP) enzymes which play crucial roles in cardiovascular diseases. Recently, a novel polymorphism in the CYP3A4 gene, IVS10 + 12G > A, named CYP3A4*1G (rs2242480), has been identified. The aim of this study was to evaluate the potential relationship between the CYP3A4*1G allele and the susceptibility of coronary heart disease (CHD). A total of 628 individuals (322 unrelated patients with CHD and 306 age- and sex-matched healthy controls) were investigated in the study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to identify CYP3A4*1G. We also analysed the functional significance of IVS10 + 12G > A using the dual-luciferase reporter assay. The results showed that the frequency of the CYP3A4*1G allele was 0.290 and the CYP3A4*1G/*1G genotype was 0.090 in the patients with CHD. The patients with the CYP3A4*1G/*1G genotype had higher CHD risk, with an odds ratio (OR) of 3.84 (p = 0.025; 95% CI = 1.32-12.65) after adjustment for conventional risk factors. A gender-dependent difference was also observed. The CYP3A4*1G/*1G frequency was significantly higher in female patients than in the controls (p = 0.034, OR = 3.02, 95% CI = 1.04-8.70). Furthermore, the dual-luciferase reporter assay indicated that the A allele at IVS10 + 12G > A had a significantly higher transcriptional activity than the G allele. Our results imply that CYP3A4*1G contributes to the susceptibility of CHD in the Chinese Han population, which may be useful for the study of specific molecular pathogenesis for CHD.
What problem does this paper attempt to address?